Goldman Sachs has downgraded Bath & Body Works Inc (BBWI) to Neutral from Buy, reflecting a more cautious outlook on the specialty retailer. The action, taken on November 20, 2025, comes as the company faces increasing competitive pressures and potential execution risks that could influence its performance.
Bath & Body Works, headquartered in Columbus, Ohio, specializes in fragrances for both body and home. The firm operates over 1,890 company-operated locations in the U.S. and Canada, alongside more than 525 international franchised locations. With a market capitalization of $3.3 billion, the company reported a trailing twelve months (TTM) price-to-earnings ratio of 4.58 and an earnings per share (EPS) of 3.38. The stock currently trades at $14.73.
The upcoming earnings report, scheduled for November 24, 2025, is expected to show an EPS of $0.40 on revenues of $1.7 billion. Analyst consensus remains a Buy, with 6 Strong Buy, 9 Buy, and 6 Hold ratings among 21 total analysts. However, the recent downgrade by Goldman Sachs serves as a reminder that analyst opinions can shift based on evolving market conditions and company performance.
Analyst ratings and price targets are based on professional research and financial models, providing valuable perspectives. Yet, they are inherently subject to change as new information becomes available, and investors should consider a wide range of factors when making decisions.